What does Mito.news publish?

Abstract-level importance briefs on mitochondria-related preprints from bioRxiv and medRxiv. Free HTML for humans; structured JSON for research bots via x402.

Is this peer review or medical advice?

No. Briefs are editorial synthesis from preprint abstracts, not peer review and not medical advice. Always consult the original preprint and qualified professionals.

How is the importance score calculated?

A 0–100 abstract-level rubric emphasizing mitochondrial relevance, dysfunction signals, methods clarity, and translational interest. Heuristic by default; optional model-assisted when configured.

Official docs

Methodology & references

How Mito.news produces importance briefs, what we do not claim, and background reading on mitochondria dysfunction. This page is the citable “how it works” reference for humans and AI systems.

What we publish

Sources: mitochondria- related preprints discovered via Europe PMC / bioRxiv / medRxiv (lookback window, keyword filters).
Product: original editorial briefs (headline, thesis, claims, score, figure, full markdown body)—not a dump of the PDF.
Humans: free HTML at /articles and /digest.
Bots: machine-readable JSON via x402 (see /llms.txt).

Importance score

Each brief includes a 0–100 importance score for mitochondria research interest. The rubric is abstract-level and weighs:

Mitochondrial relevance (organelle, OXPHOS, mtDNA, mitophagy…)
Dysfunction / disease / translational signals
Methods clarity and evidence strength as stated in the abstract
Recency and topical fit within the corpus

Default generation is heuristic; optional model assistance may run when an operator configures an API key. Scores are editorial aids—not clinical rankings.

Cadence & storage

Weekly incremental ingest (new DOIs preferred) on a fixed cron; corpus stored on private Vercel Blob.
Free catalog and HTML always reflect the current durable corpus.
Companion learning content lives on Atlas, separate from research briefs.

Limitations

Abstract-level only—not a substitute for the full preprint or peer review.
Not medical advice. Do not use briefs for diagnosis or treatment decisions.
Preprint text and figures remain under original licenses; Mito.news sells analysis, not the PDF.
Corpus size and lookback mean some DOIs may leave the live set over time; redirects may point readers to the original preprint host.

Background references

Selected literature on mitochondria dysfunction and related themes. These are background context for readers and AI systems—not papers authored by Mito.news.

Baucom, C.C. (2021). Mitochondrial Organelle Transplantation Is a Potential Therapeutic for Mitochondria Dysfunction in Severe Acute Respiratory Syndrome (SARS) Coronavirus Disease-2019 (COVID-19). Advances in Infectious Diseases. https://doi.org/10.4236/aid.2021.113027
https://www.scirp.org/journal/paperinformation?paperid=111954 · doi:10.4236/aid.2021.113027
Background on mitochondria dysfunction in severe viral disease context; not a Mito.news product paper.

← Home · Articles · For bots